Lennertz invests USD 25m in RapidAI to spur inorganic growth
September 22, 2020
The Hamburg-based family office Lennertz & Co. is investing USD 25m in RapidAI, the world leader in stroke diagnosis and therapy coordination using artificial intelligence (AI) and modern MRI and CT imaging. "With our investment, we will accelerate the company's worldwide growth, in particular by establishing a global sales force and a buy-and-build strategy, i.e. the targeted acquisition of companies," says Philipp Lennertz, managing partner of Lennertz & Co.
ⓘ This story was originally featured in our daily M&A Insights newsletter.